ALT-801 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus (T2DM)

Clinical trial NCT05134662 · COMPLETED

Trial details

NCT number: NCT05134662
Sponsor: Altimmune, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2022-02-01
Primary completion: 2023-02-03
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.